Answer
The safety and efficacy of angiotensin II (Giapreza) in children under 18 have not yet been established, and no data are available.
Sources for this answer
- GIAPREZA 2.5 mg/ml concentrate for solution for infusionPAION UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked